Cargando…
U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice
Most pathogens infect through mucosal surfaces, and parenteral immunization typically fails to induce effective immune responses at these sites. Development of oral-administered vaccines capable of inducing mucosal as well as systemic immunity while bypassing the issues of antigen degradation and im...
Autores principales: | Risso, Gabriela S., Carabajal, Marianela V., Bruno, Laura A., Ibañez, Andrés E., Coria, Lorena M., Pasquevich, Karina A., Lee, Seung-Joo, McSorley, Stephen J., Briones, Gabriel, Cassataro, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313482/ https://www.ncbi.nlm.nih.gov/pubmed/28261222 http://dx.doi.org/10.3389/fimmu.2017.00171 |
Ejemplares similares
-
Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System
por: Pasquevich, Karina A., et al.
Publicado: (2019) -
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
por: Coria, Lorena M., et al.
Publicado: (2020) -
Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from
Brucella
spp. as Nasal Adjuvant Induces a
Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk
Proteins
por: Ibañez, Andrés E., et al.
Publicado: (2013) -
Stability Studies of the Vaccine Adjuvant U-Omp19
por: Darriba, M. Laura, et al.
Publicado: (2021) -
An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
por: Pasquevich, Karina A., et al.
Publicado: (2011)